Harnessing the Power of the Immune System
The human immune system has a natural ability to identify and eliminate abnormal cells, including cancer cells. In many cases, however, cancer develops mechanisms that allow it to evade immune detection or suppress immune responses. As a result, the immune system alone may not always be able to completely eliminate malignant tumors.
Modern cancer treatment increasingly focuses on supporting and strengthening the immune system so it can more effectively recognize and destroy cancer cells.
One of the immune system’s most powerful characteristics is its ability to develop immune memory. This allows specialized immune cells to recognize and attack cancer cells even years after treatment, helping prevent recurrence if tumor cells begin to grow again.
Because of these capabilities, immunotherapy has become one of the most promising directions in modern oncology.
What Is Cellular Immunotherapy?
Cellular immunotherapy is an advanced cancer treatment that uses the patient’s own immune cells to fight cancer.
During this process, immune cells are collected from the patient’s blood and processed in a specialized laboratory. These cells are then activated, expanded, and strengthened to enhance their anti-tumor activity before being reintroduced into the patient’s body.
Once infused back into the bloodstream, these activated immune cells help the body:
- identify malignant cells
- destroy tumor cells
- strengthen the overall immune response against cancer
Because the therapy uses the patient’s own biological material, cellular immunotherapy is considered a personalized treatment approach.
Laboratory Process in Our Clinic
Our cellular laboratory performs immunotherapy procedures using carefully controlled scientific methods designed to maximize immune cell activity.
Step 1: Immune Cell Collection
The procedure begins with the collection of peripheral blood mononuclear cells (PBMCs) from the patient’s peripheral blood.
These cells contain several important immune cell populations that play key roles in anti-tumor immunity.
Step 2: T-Cell Isolation and Activation
From the PBMC population, T-lymphocytes are isolated and activated.
Activation is performed using magnetic bead technology, combined with stimulation by specific interleukins, which promote:
- T-cell proliferation
- increased immune activity
- improved anti-tumor response
The activated cells are then expanded in the laboratory to increase their numbers before infusion.
This methodology is widely used in modern immunotherapy laboratories around the world.
Our Unique Approach: Combined T Cells and NK Cells
A key feature of our therapeutic strategy is the combined activation of two powerful immune cell types.
In parallel with T-cell activation, CD34⁺ hematopoietic stem cells are isolated from the patient’s peripheral blood. These stem cells are expanded and differentiated into Natural Killer (NK) cells.
NK cells are a crucial component of the innate immune system. Unlike many other immune cells, they can recognize and destroy abnormal cells without prior sensitization.
This allows NK cells to target:
- primary tumor cells
- circulating tumor cells in the bloodstream
- metastatic cancer cells
After laboratory activation and expansion, both T cells and NK cells are infused back into the patient, creating a coordinated and powerful immune response against cancer.
Advantages of Combined Cellular Immunotherapy
The combination of activated T lymphocytes and NK cells derived from hematopoietic stem cells may significantly enhance anti-tumor activity.
These immune cells work through complementary mechanisms, strengthening the body’s ability to recognize and eliminate malignant cells.
Potential benefits of this combined approach include:
- enhanced immune response against tumors
- improved targeting of circulating cancer cells
- potential impact on metastatic lesions
- personalized immune-based therapy
By harnessing the strengths of multiple immune cell populations, combined cellular immunotherapy represents an innovative strategy in the evolving field of cancer treatment.
Leave a Reply